Kangmei Pharmaceutical Co., Ltd. (600518.SS)
- Previous Close
1.9800 - Open
2.0000 - Bid 1.9800 x --
- Ask 1.9900 x --
- Day's Range
1.9800 - 2.0100 - 52 Week Range
1.6800 - 2.9500 - Volume
132,286,701 - Avg. Volume
198,249,420 - Market Cap (intraday)
27.451B - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 28, 2019
- 1y Target Est
--
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is based in Shenzhen, China.
www.kangmei.com.cn4,409
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 600518.SS
View MorePerformance Overview: 600518.SS
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600518.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600518.SS
View MoreValuation Measures
Market Cap
27.45B
Enterprise Value
26.70B
Trailing P/E
3.30k
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.45
Price/Book (mrq)
3.82
Enterprise Value/Revenue
5.05
Enterprise Value/EBITDA
462.46
Financial Highlights
Profitability and Income Statement
Profit Margin
4.90%
Return on Assets (ttm)
1.21%
Return on Equity (ttm)
3.71%
Revenue (ttm)
5.21B
Net Income Avi to Common (ttm)
255.55M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
773.59M
Total Debt/Equity (mrq)
3.05%
Levered Free Cash Flow (ttm)
-195.77M